PerkinElmer (PKI) Tops Q1 EPS by 3c, Revenues Beat; Raises FY19 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
PerkinElmer Announces Financial Results for the First Quarter of 2019
April 25, 2019 4:15 PM EDTRevenue of $648.7 million; 1% Reported growth; Organic growth of 5% GAAP EPS from continuing operations of $0.32; Adjusted EPS of $0.69 Acquisition of Cisbio Bioassays, a leading custom assay service provider, bolsters position in life sciences and diagnostics markets FY19 GAAP earnings per share guidance range of $2.85 to $2.90 from continuing operations; Raises Adjusted EPS guidance to $4.02-4.07
WALTHAM, Mass.--(BUSINESS WIRE)--... More
